Skip to content
10-K

Annual Report

SONNET BIOTHERAPEUTICS HOLDINGS, INC.

0001493152-25-027978

← back to feed
Filed
Dec 16, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Dec 12, 2025 1 sh
Shares Diluted FY 2025 · Sep 30, 2025 4.08M sh
Shares Diluted FY 2025 · Sep 30, 2024 655.24K sh
Operating Cash Flow FY 2025 · Sep 30, 2025 −$12.83M
Operating Cash Flow FY 2025 · Sep 30, 2024 −$8.61M
Cash And Equivalents FY 2025 · Sep 30, 2025 $5.12M
Cash And Equivalents FY 2025 · Sep 30, 2024 $149.46K
Stockholders Equity FY 2025 · Sep 30, 2025 $10.79M
Stockholders Equity FY 2025 · Sep 30, 2024 −$485.74K
Stockholders Equity FY 2025 · Sep 30, 2023 −$225.98K
Current Liabilities FY 2025 · Sep 30, 2025 $4.1M
Current Liabilities FY 2025 · Sep 30, 2024 $3.21M
Total Liabilities FY 2025 · Sep 30, 2025 $4.1M
Total Liabilities FY 2025 · Sep 30, 2024 $3.26M
Current Assets FY 2025 · Sep 30, 2025 $14.34M
Current Assets FY 2025 · Sep 30, 2024 $2.12M
Total Assets FY 2025 · Sep 30, 2025 $14.88M
Total Assets FY 2025 · Sep 30, 2024 $2.77M
Eps Diluted FY 2025 · Sep 30, 2025 −$3.95
Eps Diluted FY 2025 · Sep 30, 2024 −$11.35
Eps Basic FY 2025 · Sep 30, 2025 −$3.95
Eps Basic FY 2025 · Sep 30, 2024 −$11.35
Sga Expense FY 2025 · Sep 30, 2025 $8.49M
Sga Expense FY 2025 · Sep 30, 2024 $6.13M
Rd Expense FY 2025 · Sep 30, 2025 $8.36M
Rd Expense FY 2025 · Sep 30, 2024 $5.74M
Net Income FY 2025 · Sep 30, 2025 −$16.01M
Net Income FY 2025 · Sep 30, 2024 −$7.44M
Operating Income FY 2025 · Sep 30, 2025 −$15.84M
Operating Income FY 2025 · Sep 30, 2024 −$11.85M
Revenue FY 2025 · Sep 30, 2025 $1M
Revenue FY 2025 · Sep 30, 2024 $18.63K